Cargando…
Device infections related to cardiac resynchronization therapy in clinical practice–An analysis of its prevalence, risk factors and routine surveillance at a single center university hospital
BACKGROUND: The implantation rates of cardiac implantable electronic devices have steadily increased, accompanied by a steeper rise of device related infections (DRI). HYPOTHESIS: The prevalence of DRI for cardiac resynchronization therapy (CRT) is higher in clinical practice than reported previousl...
Autores principales: | Ostrowska, Bozena, Gkiouzepas, Spyridon, Kurland, Siri, Blomström‐Lundqvist, Carina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207984/ https://www.ncbi.nlm.nih.gov/pubmed/34032293 http://dx.doi.org/10.1002/clc.23620 |
Ejemplares similares
-
Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis
por: Blomstrom-Lundqvist, Carina, et al.
Publicado: (2021) -
The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial
por: Wikstrom, Gerhard, et al.
Publicado: (2009) -
Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
por: Gandra, Shravanthi R., et al.
Publicado: (2016) -
Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE‐AF registry
por: Contreras, Johanna P., et al.
Publicado: (2019) -
Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban
por: Tamayo, Sally, et al.
Publicado: (2015)